Not only can the drug metformin help to effectively manage type 2 diabetes, but it may also give older women a better chance ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

Treating kidney disease GLP-1s show higher risk than SGLT2 inhibitors in kidney outcomes, but lower albuminuria and mortality rates.

GLP-1 weight loss drugs have quickly moved from medical journals to household conversations, reshaping how Americans think ...

NICE recommends SGLT-2 inhibitors with metformin at diagnosis, citing major cardiovascular, renal, and mortality benefits.

A US team has linked metformin use in older women with type 2 diabetes to a 30% lower risk of dying before 90. But does this ...

Weight loss medications Mounjaro and Zepbound, which contain the active ingredient tirzepatide, may lower the risk of ...

By Tarun Sai Lomte Widely used weight-loss and diabetes drugs show clear benefits, but emerging evidence clarifies their side effects, rare risks, and what clinicians should monitor long term. Review: ...

KUALA LUMPUR, Feb 10 — Often referred to as a ‘miracle drug’, glucagon-like peptide-1 (GLP-1) ...

Ozempic's rival is generating blockbuster revenue and gaining market share.